Quantcast

Latest Organic chemistry Stories

2014-08-25 08:27:26

New Indication in Chronic Pain Marks Company's Third FDA Approval in Less Than a Year PHILADELPHIA, Aug. 25, 2014 /PRNewswire/ -- Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today the United States Food and Drug Administration (FDA) has approved ZORVOLEX® (diclofenac) capsules, a nonsteroidal anti-inflammatory drug (NSAID), for the management of osteoarthritis pain. This marks the second indication...

2014-08-22 23:04:27

ReportsnReports.com adds “2014 Deep Research Report on Global and China DINP Plasticizer Industry” and “2014 Deep Research Report on Global and China DIDP Plasticizer Industry” reports to its research database. (PRWEB) August 22, 2014 2014 Deep Research Report on Global and China DINP Plasticizer Industry is a professional and in-depth research report on the DINP Plasticizer market. The report introduces DINP Plasticizer basic information, including its definition, classification,...

2014-08-22 16:23:16

LONDON, Aug. 22, 2014 /PRNewswire/ -- ViiV Healthcare announced today that the US Food and Drug Administration (FDA) has approved Triumeq(®) (abacavir 600mg, dolutegravir 50mg and lamivudine 300mg) tablets for the treatment of HIV-1 infection.(1) Triumeq is ViiV Healthcare's first dolutegravir-based fixed-dose combination, offering many people living with HIV the option of a single-pill regimen that combines the integrase strand transfer inhibitor (INSTI) dolutegravir, with the nucleoside...

2014-08-21 23:03:25

The Firm is evaluating Xarelto lawsuits on behalf of individuals who suffered uncontrollable internal bleeding or other serious injuries allegedly due to their use of the blood thinner. New York, New York (PRWEB) August 21, 2014 Xarelto lawsuit (http://www.xareltolawsuitcenter.com/) filings that allege the blood thinner caused patients to suffer uncontrollable internal bleeding and other serious injuries continue to mount in U.S. courts, Bernstein Liebhard LLP reports. According to court...

2014-08-21 12:26:00

Abuse-Resistant Drugs, along with Rehabilitation and Regulation Seen as Essential CINCINNATI, Aug. 21, 2014 /PRNewswire/ -- Seventy-one percent of Americans believe the abuse of strong prescription pain medications such as OxyContin is a serious public health and safety issue in the United States, according to findings from a survey released today by Repass & Partners, a Cincinnati based research firm. "Americans understand the severity of the prescription medication abuse...

2014-08-19 23:10:03

The firm currently represents patients who allege that they have suffered serious side effects from use of anticoagulants Pradaxa and Xarelto. Rockville Centre, NY (PRWEB) August 19, 2014 The Rottenstein Law Group, a national personal injury law firm that represents persons who believe they were injured by anticoagulants such as Pradaxa (http://www.rotlaw.com/pradaxa-lawsuit/) and Xarelto (http://www.rotlaw.com/xarelto/), has learned that the federal court overseeing the consolidated...

2014-08-19 23:03:39

The North American Urea Formaldehyde Resin Market report defines and segments the urea formaldehyde resin market in North America with analysis and forecast of revenue. http://www.micromarketmonitor.com/market/north-america-urea-formaldehyde-resin-5727117393.html (PRWEB) August 19, 2014 The North American Urea Formaldehyde Resin Market report defines and segments the urea formaldehyde resin market in North America with analysis and forecast of revenue. Browse through the TOC of the...

2014-08-19 23:02:22

The Firm is representing men and boys in Risperdal lawsuits who allegedly developed gynecomastia (male breast growth) due to their use of the atypical antipsychotic medication. New York, New York (PRWEB) August 19, 2014 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com) mount in U.S. courts, Bernstein Liebhard LLP notes the publication of a new study that suggests the use of atypical antipsychotic medications may increase the risk of acute kidney injury in elderly patients....

2014-08-19 12:28:29

Reimbursement and Out-of-Pocket Costs are the Leading Reasons for Treatment Discontinuation, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug. 19, 2014 /PRNewswire/ -- Decision Resources Group finds that, for the treatment of hepatitis C virus (HCV) infections, 40 percent of surveyed HCV treating specialists expect to prescribe Gilead's investigational fixed-dose combination of sofosbuvir/ledipasvir in the next six months to their genotype 1 patients. Analysis of...

2014-08-19 08:29:39

DUBLIN, Aug. 19, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed positive topline results from RECLAIM-1 and -2, pivotal Phase III studies evaluating the potential for the investigational antibiotic, ceftazidime-avibactam as a treatment for adult hospitalized patients with complicated intra-abdominal infections. Logo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO Ceftazidime-avibactam consists of a cephalosporin (ceftazidime), an established treatment for...


Latest Organic chemistry Reference Libraries

Organometallics
2012-05-17 15:18:17

Organometallics is a peer-reviewed scientific journal published by the American Chemical Society. As of May 2012, the editor-in-chief is John A. Gladysz. Organometallics publishes records in one of the most active fields for organometallic, inorganic, organic, and materials chemists. Articles, communications, mini-reviews, and notes detail the synthesis, structure, bonding, chemical reactivity and reaction mechanisms, and applications of organometallic and organometalloidal compounds....

Synthetic Metals
2012-05-17 14:54:38

Synthetic Metals is a peer-reviewed scientific journal published by Elsevier. It covers all aspects of electronic polymers and electronic molecular materials. It is an international medium for the rapid publication of original research papers, short communications and subject reviews dealing with research on and applications of electronic polymers and electronic molecular materials including novel carbon architectures. Original manuscripts on chemical, electrochemical, electrical, photonic...

More Articles (2 articles) »
Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related